Syncromune: Clinical-stage biopharma developing intratumoral immunotherapies for solid tumors.
5+ YOEPh.D. (5+ years) or M.S. (10+ years) in pharmaceutical sciences or related field; expertise in biologic formulation, process development, technology transfer, GMP manufacturing, CMC documentation, DoE/QbD, and managing CDMOs/CROs.
Design of Experiments (DoE), Quality by Design (QbD)
Syncromune: Clinical-stage biopharma developing intratumoral immunotherapies for solid tumors.
15+ YOEMaster's/PhD in chemistry/biochemistry/analytical science, 15+ years analytical development for biologics, experience with method development/validation, GMP/GLP and regulatory submissions (IND/BLA), CRO/CDMO management, and leadership of analytical teams.
Syncromune: Clinical-stage biopharma developing intratumoral immunotherapies for solid tumors.
5+ YOEPh.D. or M.S. in relevant field, 5+ years pharma/biotech analytical development experience, separation science expertise, cGMP/ICH knowledge, CDMO/CTL management experience, method development/validation experience, willingness to travel up to 25%.
Chromatography, Liquid Chromatography, Spectroscopy, Mass Spectrometry